Peptides Codex
Home
Vasopressin analog

Desmopressin

Desmopressin (DDAVP) is a synthetic nonapeptide analog of vasopressin, modified by deamination of the first residue and a D-arginine substitution. These changes favor V2-mediated antidiuresis while minimizing V1 vasoconstriction, and it is an approved therapeutic for diabetes insipidus, nocturnal enuresis and some bleeding disorders. This page is educational and not medical advice.

By The Peptides Codex Editorial TeamReviewed July 10, 2026
Length
9 aa
Class
Vasopressin analog
Function
Selective V2 vasopressin receptor agonist
Context
Approved for diabetes insipidus, bedwetting and certain bleeding disorders

A vasopressin analog engineered for antidiuretic action without vasoconstriction.

Also known as: DDAVP

Part of the Foundational & therapeutic peptides cluster

Overview

Desmopressin (DDAVP) is a synthetic nonapeptide analog of vasopressin, modified by deamination of the first residue and a D-arginine substitution. These changes favor V2-mediated antidiuresis while minimizing V1 vasoconstriction, and it is an approved therapeutic for diabetes insipidus, nocturnal enuresis and some bleeding disorders. This page is educational and not medical advice.

Source & context

Biological / chemical source: Synthetic nonapeptide analog of vasopressin

Primary research or clinical context: Approved for diabetes insipidus, bedwetting and certain bleeding disorders

Selective redesign

Two structural changes to vasopressin extend the half-life and shift activity toward the V2 receptor. The result is strong water-retaining action with little blood-pressure effect, a frequently cited example of receptor selectivity achieved by minimal peptide modification.

Hemostatic use

Beyond fluid balance, desmopressin triggers release of von Willebrand factor and factor VIII from endothelial stores, which is why it is used in mild hemophilia A and von Willebrand disease. This dual profile makes it a versatile teaching example of peptide pharmacology.

FAQ about Desmopressin

What is Desmopressin?+

Desmopressin (DDAVP) is a synthetic nonapeptide analog of vasopressin, modified by deamination of the first residue and a D-arginine substitution. These changes favor V2-mediated antidiuresis while minimizing V1 vasoconstriction, and it is an approved therapeutic for diabetes insipidus, nocturnal enuresis and some bleeding disorders. This page is educational and not medical advice.

Is Desmopressin an approved medicine?+

Desmopressin: Approved for diabetes insipidus, bedwetting and certain bleeding disorders. Always follow licensed medical guidance for approved products.

What is the typical length of Desmopressin?+

Desmopressin is commonly described as approximately 9 amino acids (Vasopressin analog).

Related peptides

References & further reading

  1. 1.Wikipedia — Desmopressin
  2. 2.PubChem — compound summary for Desmopressin (CID 5311065)
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Desmopressin educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.